511 related articles for article (PubMed ID: 28490586)
1. Deletion of the
Bravo Cruz AG; Han A; Roy EJ; Guzmán AB; Miller RJ; Driskell EA; O'Brien WD; Shisler JL
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490586
[TBL] [Abstract][Full Text] [Related]
2. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
J Virol; 2019 May; 93(10):. PubMed ID: 30814284
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection.
Benfield CTO; Ren H; Lucas SJ; Bahsoun B; Smith GL
J Gen Virol; 2013 Jul; 94(Pt 7):1647-1657. PubMed ID: 23580427
[TBL] [Abstract][Full Text] [Related]
4. Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response.
Di Pilato M; Mejías-Pérez E; Sorzano COS; Esteban M
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424281
[TBL] [Abstract][Full Text] [Related]
5. Suppression of innate immunity by the vaccinia virus protein N1 promotes skin microbiota expansion and increased immune infiltration following vaccination.
Shmeleva EV; Syafiq D; Moldoveanu AL; Ferguson BJ; Smith GL
J Gen Virol; 2022 Nov; 103(11):. PubMed ID: 36748513
[TBL] [Abstract][Full Text] [Related]
6. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
Arndt WD; Cotsmire S; Trainor K; Harrington H; Hauns K; Kibler KV; Huynh TP; Jacobs BL
J Virol; 2015 Oct; 89(20):10489-99. PubMed ID: 26246580
[TBL] [Abstract][Full Text] [Related]
7. Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.
Sumner RP; Ren H; Ferguson BJ; Smith GL
Vaccine; 2016 Sep; 34(40):4827-34. PubMed ID: 27544585
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence.
Strnadova P; Ren H; Valentine R; Mazzon M; Sweeney TR; Brierley I; Smith GL
PLoS Pathog; 2015 Sep; 11(9):e1005151. PubMed ID: 26334635
[TBL] [Abstract][Full Text] [Related]
9. The Vaccinia virus complement control protein modulates adaptive immune responses during infection.
Girgis NM; Dehaven BC; Xiao Y; Alexander E; Viner KM; Isaacs SN
J Virol; 2011 Mar; 85(6):2547-56. PubMed ID: 21191012
[TBL] [Abstract][Full Text] [Related]
10. Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated.
Willis KL; Langland JO; Shisler JL
J Biol Chem; 2011 Mar; 286(10):7765-7778. PubMed ID: 21183678
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor.
Chen RA; Jacobs N; Smith GL
J Gen Virol; 2006 Jun; 87(Pt 6):1451-1458. PubMed ID: 16690909
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence.
Ferguson BJ; Benfield CTO; Ren H; Lee VH; Frazer GL; Strnadova P; Sumner RP; Smith GL
J Gen Virol; 2013 Sep; 94(Pt 9):2070-2081. PubMed ID: 23761407
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus F5 is required for normal plaque morphology in multiple cell lines but not replication in culture or virulence in mice.
Dobson BM; Procter DJ; Hollett NA; Flesch IE; Newsome TP; Tscharke DC
Virology; 2014 May; 456-457():145-56. PubMed ID: 24889234
[TBL] [Abstract][Full Text] [Related]
14. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha.
Backes S; Sperling KM; Zwilling J; Gasteiger G; Ludwig H; Kremmer E; Schwantes A; Staib C; Sutter G
J Gen Virol; 2010 Feb; 91(Pt 2):470-82. PubMed ID: 19846675
[TBL] [Abstract][Full Text] [Related]
15. Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden.
Parekh NJ; Krouse TE; Reider IE; Hobbs RP; Ward BM; Norbury CC
PLoS Pathog; 2019 Oct; 15(10):e1007778. PubMed ID: 31603920
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus K1L and C7L inhibit antiviral activities induced by type I interferons.
Meng X; Jiang C; Arsenio J; Dick K; Cao J; Xiang Y
J Virol; 2009 Oct; 83(20):10627-36. PubMed ID: 19656868
[TBL] [Abstract][Full Text] [Related]
17. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.
Deng L; Dai P; Ding W; Granstein RD; Shuman S
J Virol; 2006 Oct; 80(20):9977-87. PubMed ID: 17005676
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence.
Ember SWJ; Ren H; Ferguson BJ; Smith GL
J Gen Virol; 2012 Oct; 93(Pt 10):2098-2108. PubMed ID: 22791606
[TBL] [Abstract][Full Text] [Related]
20. Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L-C7L- Mutant.
Sivan G; Ormanoglu P; Buehler EC; Martin SE; Moss B
mBio; 2015 Aug; 6(4):e01122. PubMed ID: 26242627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
